Miami Cancer Institute-Baptist Hospital ( Site 0068) — Miami, Florida

Miami Cancer Institute-Baptist Hospital ( Site 0068) is a clinical research site located in Miami, Florida, United States 33176.

Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Miami Cancer Institute-Baptist Hospital ( Site 0068) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-small Cell Lung Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Miami

Browse all research sites in Florida · View every site in Miami

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Miami Cancer Institute-Baptist Hospital ( Site 0068)?

Miami Cancer Institute-Baptist Hospital ( Site 0068) has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Miami Cancer Institute-Baptist Hospital ( Site 0068) conducted?

Miami Cancer Institute-Baptist Hospital ( Site 0068) has 1 clinical trials on record, with 1 currently active. Their work covers Non-small Cell Lung Cancer.

Is Miami Cancer Institute-Baptist Hospital ( Site 0068) accredited by Crixeo Clinical Trials?

Miami Cancer Institute-Baptist Hospital ( Site 0068) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Miami Cancer Institute-Baptist Hospital ( Site 0068)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.